ÃÖ±Ù ¼¼°èÀûÀÎ SARS-COVID-19 »çÅ·ΠÀÎÇØ °ü·Ã Á¦Ç°ÀÇ »ý»ê ¿äûÀÌ ÆøÁÖÇϰí ÀÖ´Â »óȲÀÔ´Ï´Ù.
ÀÌ¿¡ µû¶ó SARS-COVID-19 °ü·Ã ¼¿ÀÌ Æ÷ÇÔµÈ Á¦Ç° Áß ¾Æ·¡ stock¿¡ ÇØ´çµÇ´Â Á¦Ç°Àº ´õ ÀÌ»ó customÁ¦ÀÛÀÌ ºÒ°¡´ÉÇϸç,
»çÀü ÁغñµÈ stock Á¦Ç°À¸·Î¸¸ ÁÖ¹®ÀÌ °¡´ÉÇÔÀ» ¾Ë·Áµå¸³´Ï´Ù. (¾Æ·¡ list È®ÀÎ ¹Ù¶ø´Ï´Ù.)
Stock Á¦Ç°Àº ±âÁ¸ customÁ¦ÀÛ º¸´Ù ºü¸¥ ¹è¼ÛÀ» Á¦°øÇØ µå¸± ¼ö ÀÖ´Â ÀåÁ¡ÀÌ ÀÖ½À´Ï´Ù.
Àü¼¼°èÀû ºñ»ó »çÅ·ΠÀÎÇÑ ºÎµæÀÌÇÑ °áÁ¤À¸·Î °í°´´ÔµéÀÇ ¾çÇØ ºÎŹ µå¸³´Ï´Ù.
COVID detection oligo¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡
µû¶ó IDT´Â º¸´Ù ºü¸¥ ´ëÀÀÀ» À§ÇØ Á¦Á¶ °øÁ¤À» À籸¼º ÇÏ¿© ÇöÀç ½Ì°¡Æú¿¡¼µµ COVID-19 °ü·Ã ÁÖ¹®À» ÇÕ¼ºÇϰí ÀÖÀ½À» ¾Ë·Áµå¸³´Ï´Ù. ÀÌ·± ³ë·ÂÀ¸·Î ±âÁ¸ ÁÖ¹®º¸´Ù º¸´Ù ºü¸¥ TAT Á¦°øÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ´Ü, ¡Ã46 bases´Â ½Ì°¡ÆúÀÌ ¾Æ´Ñ ´Ù¸¥ facility (US/ Belgium) ¿¡¼
ÇÕ¼ºÀÌ ÁøÇàµÇ¿À´Ï È¥µ¿ ¾øÀ¸½Ã±æ ¹Ù¶ø´Ï´Ù. ÀÌ´Â ÃÖ°íÀÇ Ç°Áú·Î Á¦°øÇØ µå¸®±â À§ÇÑ IDTÀÇ ¹æÄ§ÀÌ¿À´Ï ¾çÇØ ºÎŹ µå¸³´Ï´Ù.
°ü·Ã ¹®ÀÇ´Â koreacustcare@idtdna.comÀ¸·Î ¿¬¶ô ºÎŹ µå¸³´Ï´Ù. °¨»çÇÕ´Ï´Ù.
<Stock Á¦Ç° ¸ñ·Ï> - ÇØ´ç list´Â ÷ºÎ ÆÄÀϷεµ ¾÷·Îµå ÇÏ¿´½À´Ï´Ù.
* Probe ´Â FAM/ZEN/IBFQ ÀÔ´Ï´Ù.
* Individual primers and probes, HPLC purified, and delivered in IDTE (1X TE buffer) pH 7.5 at 100µM. Available in normalized deliverables to the amounts indicated below and shipped ambient.
* ¾Æ·¡ stock Á¦Ç°Àº Functional Test (NTC µî), HPLC purification ¹× Template control process·Î GMP½Ã¼³¿¡¼ »ý»êµÇ¾ú½À´Ï´Ù.
* Control plasmids contain the complete envelope gene and a portion of the RNA-dependent RNA polymerase (RdRP) from 2019-nCoV. The 2019-nCoV Charité/Berlin qPCR Probe Assays target regions within the nCoV envelope gene and the RdRP gene which are present in the 2019-nCoV_E Positive Control and 2019-nCoV_RdRP positive control plasmids. Delivered at 250µL (200,000 copies/µL) in IDTE pH 8.0. Shipped at ambient temperature.
Cat# |
Product
Name |
Korea
List Price |
Sequence |
¡¡ |
2019-nCov CDC EUA Kit, 1000 rxn |
347,000 |
¡¡ |
¡¡10006896 |
2019-nCoV_E Positive Control |
108,000 |
2019-nCoV_RdRp (ORF1ab) control: Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome (GenBank: NC_045512.2) |
¡¡10006897 |
2019-nCoV_RdRp (ORF1ab) Positive Control |
108,000 |
2019-nCoV_E control: Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-Hu-1, complete genome (GenBank: NC_045512.2) |
10006804 |
E Assay_First Line Screening, 1,000 Rxns |
852,000 |
¡¡ |
10006889 |
E_Sarbeco_F1 Forward Primer, 100 nmol |
318,000 |
ACAGGTACGTTAATAGTTAATAGCGT |
10006892 |
E_Sarbeco_P1 Probe, 25 nmol |
397,000 |
ACACTAGCCATCCTTACTGCGCTTCG |
10006891 |
E_Sarbeco_R2 Reverse Primer, 100 nmol |
318,000 |
ATATTGCAGCAGTACGCACACA |
10006890 |
E_Sarbeco_R2 Reverse Primer, 50 nmol |
217,000 |
ATATTGCAGCAGTACGCACACA |
10006830 |
nCOV_N1 Forward Primer Aliquot, 100 nmol |
318,000 |
GACCCCAAAATCAGCGAAAT |
10006821 |
nCOV_N1 Forward Primer Aliquot, 50 nmol |
217,000 |
GACCCCAAAATCAGCGAAAT |
10006823 |
nCOV_N1 Probe Aliquot, 25 nmol |
397,000 |
ACCCCGCATTACGTTTGGTGGACC |
10006832 |
nCOV_N1 Probe Aliquot, 50 nmol |
599,000 |
ACCCCGCATTACGTTTGGTGGACC |
10006831 |
nCOV_N1 Reverse Primer Aliquot, 100 nmol |
318,000 |
TCTGGTTACTGCCAGTTGAATCTG |
10006822 |
nCOV_N1 Reverse Primer Aliquot, 50 nmol |
217,000 |
TCTGGTTACTGCCAGTTGAATCTG |
10006833 |
nCOV_N2 Forward Primer Aliquot, 100 nmol |
318,000 |
TTACAAACATTGGCCGCAAA |
10006824 |
nCOV_N2 Forward Primer Aliquot, 50 nmol |
217,000 |
TTACAAACATTGGCCGCAAA |
10006826 |
nCOV_N2 Probe Aliquot, 25 nmol |
397,000 |
ACAATTTGCCCCCAGCGCTTCAG |
10006835 |
nCOV_N2 Probe Aliquot, 50 nmol |
599,000 |
ACAATTTGCCCCCAGCGCTTCAG |
10006834 |
nCOV_N2 Reverse Primer Aliquot, 100 nmol |
318,000 |
GCGCGACATTCCGAAGAA |
10006825 |
nCOV_N2 Reverse Primer Aliquot, 50 nmol |
217,000 |
GCGCGACATTCCGAAGAA |
10006815 |
nCOV_N3 Forward Primer Aliquot, 100 nmol |
318,000 |
GGGAGCCTTGAATACACCAAAA |
10006813 |
nCOV_N3 Forward Primer Aliquot, 50 nmol |
217,000 |
GGGAGCCTTGAATACACCAAAA |
10006816 |
nCOV_N3 Reverse Primer Aliquot, 100 nmol |
318,000 |
TGTAGCACGATTGCAGCATTG |
10006814 |
nCOV_N3 Reverse Primer Aliquot, 50 nmol |
217,000 |
TGTAGCACGATTGCAGCATTG |
10006805 |
RdRp Assay_Confirmatory, 1,000 Rxns |
852,000 |
¡¡ |
10006806 |
RdRP Assay_Discriminatory, 1,000 Rxns |
852,000 |
¡¡ |
10006882 |
RdRP_SARSr_F2 Forward Primer, 100 nmol |
318,000 |
GTGARATGGTCATGTGTGGCGG |
10006860 |
RdRP_SARSr_F2 Forward Primer, 50 nmol |
217,000 |
GTGARATGGTCATGTGTGGCGG |
10006884 |
RdRP_SARSr_P1 Probe, 25 nmol |
397,000 |
CCAGGTGGWACRTCATCMGGTGATGC |
10006885 |
RdRP_SARSr_P1 Probe, 50 nmol |
599,000 |
CCAGGTGGWACRTCATCMGGTGATGC |
10006886 |
RdRP_SARSr_P2 Probe, 25 nmol |
397,000 |
CAGGTGGAACCTCATCAGGAGATGC |
10006887 |
RdRP_SARSr_P2 Probe, 50 nmol |
599,000 |
CAGGTGGAACCTCATCAGGAGATGC |
10006883 |
RdRP_SARSr_R1 Reverse Primer, 100 nmol |
318,000 |
CARATGTTAAASACACTATTAGCATA |
10006881 |
RdRP_SARSr_R1 Reverse Primer, 50 nmol |
217,000 |
CARATGTTAAASACACTATTAGCATA |
10006836 |
RNase P Forward Primer Aliquot, 100 nmol |
318,000 |
AGATTTGGACCTGCGAGCG |
10006827 |
RNase P Forward Primer Aliquot, 50 nmol |
217,000 |
AGATTTGGACCTGCGAGCG |
10006837 |
RNase P Reverse Primer Aliquot, 100 nmol |
318,000 |
GAGCGGCTGTCTCCACAAGT |
10006828 |
RNase P Reverse Primer Aliquot, 50 nmol |
217,000 |
GAGCGGCTGTCTCCACAAGT |
10006829 |
RNase P Probe Aliquot, 25 nmol |
397,000 |
TTCTGACCTGAAGGCTCTGCGCG |
10006838 |
RNase P Probe Aliquot, 50 nmol |
599,000 |
TTCTGACCTGAAGGCTCTGCGCG |
10006888 |
E_Sarbeco_F1 Forward Primer, 50 nmol |
217,000 |
¡¡ |
10006893 |
E_Sarbeco_P1 Probe, 50 nmol |
599,000 |
ACACTAGCCATCCTTACTGCGCTTCG |
Probe ´Â FAM/ZEN/IBFQ ÀÔ´Ï´Ù. |
|
10006625 |
2019-nCoV_N_Positive
Control |
117,000 |
|
10006626 |
Hs_RPP30 Positive Control |
93,600 |
|
10006713 |
2019-nCOV RUO Kit, 500 rxn |
154,440 |
|
|
|
|
|
|
|
|
|
|